Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.
about
Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseasesMultipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver diseaseStem cell-based regenerative opportunities for the liver: State of the art and beyondMesenchymal stem cell therapy for liver fibrosisIn Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver DiseasesMesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Mesenchymal stem cell-derived molecules reverse fulminant hepatic failureHuman Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators.Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation.Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Bone Marrow Stem Cells Anti-liver Fibrosis Potency: Inhibition of Hepatic Stellate Cells Activity and Extracellular Matrix Deposition.Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis.Bone marrow stem cells and liver regenerationThe role of stem cells in liver repair and fibrosisCharacterization and function of histamine receptors in human bone marrow stromal cells.Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis.Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration.Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1.Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burnMesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor ModelMesenchymal stem cells as therapeutics and vehicles for gene and drug deliveryEthanol and liver: recent insights into the mechanisms of ethanol-induced fatty liverIn vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injuryUse of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice.Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis.Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathwayMesenchymal Bone Marrow-derived Stem Cells Transplantation in Patients with HCV Related Liver Cirrhosis.MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells.Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis.Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice.Current status and future prospects of mesenchymal stem cell therapy for liver fibrosisLong-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failureA glycosaminoglycan based, modular tissue scaffold system for rapid assembly of perfusable, high cell density, engineered tissues.Mesenchymal stromal cells as supportive cells for hepatocytes.Unexpected roles for bone marrow stromal cells (or MSCs): a real promise for cellular, but not replacement, therapyEffect of undifferentiated versus hepatogenic partially differentiated mesenchymal stem cells on hepatic and cognitive functions in liver cirrhosis.Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma.
P2860
Q26749647-CDB31EDB-5221-4F50-83DE-B83E03382B9EQ26769618-1C43681D-690E-4FED-951F-81833613415CQ26775924-01BBB8CC-8008-4973-A473-4FE72C00F9B1Q26782128-657FD9D7-8D3F-4A9C-B873-8CE24D8D8A80Q26782994-F00B7FC6-8D85-461F-BE64-F57BA447CC97Q26796475-61027EA2-EBD0-4502-8C7A-F43E7F322D07Q33300346-04F8EE13-3B74-41B4-8A36-0A5E704ED67EQ33722100-E73AD4D0-360C-4ADF-AF48-CDDAFC9A623EQ33768416-20CE2E7D-96E4-4E34-ACC5-51D5A86D8E4CQ33818431-0580BDB1-9902-4532-9931-4E66ACB19BE4Q33847521-51CFD0D5-8437-4FE2-9FC2-AFD0CAF7A6BDQ33887116-17358527-6558-41AC-930C-FF53E97FB0FDQ33903059-241E524F-8FD9-4D62-A7E5-B3C5ABB1A71BQ33925732-B3704517-469F-4A41-B2F6-6E9FD4864888Q34066174-1C85519E-F1BC-4D2D-9B1B-F76AE85EA590Q34116253-AE68B23A-F59E-4A8D-AA25-358D358DFCC1Q34150013-87F2FCC2-C1B7-4128-84A2-BB510051FF4EQ34183422-39ED2D70-9367-4BFD-8F51-8ED4F9C6AA47Q34213386-C7D793F6-5D39-4A59-A2AA-08C4ADB6185BQ34343680-E2C3FB76-5CEE-4A7A-BC34-278DE29AE0CAQ34349428-63F4A96C-37B1-470D-BFF7-325757CF8DA4Q34405039-67C23109-22FD-4C54-8DD8-C44BF98F9B70Q34701304-432F1270-2B79-4CB6-A019-687535373D73Q34985947-CD2A9CA4-FD94-4709-B21A-9C833B40EE9EQ35025219-6ED2A5CB-8E19-4B20-9379-6FED207D0655Q35620356-0B42966C-8186-4765-A8FA-0AAB6D66BF57Q35803687-170AA6B1-1690-4BBA-9A58-DB16FC63DB34Q35905940-5E5FAA57-AF32-4BF2-9A38-7916C424473DQ36059842-7DF60382-019B-4151-A7DE-238E3253D690Q36228005-3AC6B409-5B31-4E0D-9486-200BCCA4A0B2Q36353622-766DE100-2259-4291-972C-FEEAE5557199Q36560851-FCDDAC3F-2144-4B87-BC54-165A3482C200Q37050899-9C2C049D-7C75-4AD7-8646-9C73654EFDE0Q37430773-38A43CE2-D91A-4E9F-9871-45E995F0BE24Q37471408-F9B7367A-3AB2-4061-A03B-17830668B510Q37495735-B39AA354-774A-4A98-A5F2-FB065DAF536BQ37544251-CF631AA8-E54F-4F73-88DF-55B3162F11AEQ37572913-1C1F2668-E38C-49FC-AAAF-5C03AA683E22Q37654580-8AC87DC0-491B-4B46-A97E-AC028A01AEB1Q37707034-1D67E542-C43C-4ABE-A3DD-07324E0171F4
P2860
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.
@ast
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.
@en
type
label
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.
@ast
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.
@en
prefLabel
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.
@ast
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.
@en
P2093
P2860
P1476
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.
@en
P2093
Arno W Tilles
Biju Parekkadan
Daan van Poll
François Berthiaume
Martin L Yarmush
Naoya Kobayashi
Zaki Megeed
P2860
P304
P356
10.1016/J.BBRC.2007.05.150
P407
P577
2007-05-30T00:00:00Z